Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor
2016 ◽
Vol 22
(11)
◽
pp. 946.e1-946.e8
◽
2013 ◽
Vol 56
(3)
◽
pp. 339-343
◽
2015 ◽
Vol 19
(1)
◽
pp. 58-64
◽
2013 ◽
Vol 58
(2)
◽
pp. 427-431
◽
2006 ◽
Vol 57
(4)
◽
pp. 795-796
◽
2011 ◽
Vol 17
(11)
◽
pp. 1674-1680
◽
2017 ◽
Vol 95
(2)
◽
pp. 214-217
◽